Clinical Trial Update: NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating NOVA22007 (cyclosporine) at 0.05% and 0.1% versus vehicle for dry eye; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• NOVA22007 0.05% cyclosporine ophthalmic solution (cyclosporine)
• NOVA22007 0.1% cyclosporine ophthalmic solution (cyclosporine)

Snippet

Sponsor: Santen SAS | Conditions: Dry Eye | Phase 2 | Status: COMPLETED